The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.

Also called NCT05811364

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 244 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05811364
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Germany, Italy, Netherlands, New Zealand, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05811364. Randomized; double masking; primary purpose treatment. Start 2023-10-17 (actual); primary completion 2028-03-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Condition
Aortoiliac Occlusive Disease
Condition
Peripheral Arterial Disease
Intervention (Device)
Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
Intervention (Device)
Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct05811364
Content hash
5156d692f33edeb15fd09887c380051c9f60111eff9ed0cd77ef01f74302913c